CIK 0001822462 · Non-accelerated filer<br>Smaller reporting company
Foghorn Therapeutics Inc.
Sign in to watch- Ticker
- FHTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-586-3100
- Business address
- 500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-24 | Gallagher Neil Director | Grant or award · Stock Options (Right to buy) | +28,000 | $4.08 | $114K | 28,000 |
| 2026-06-24 | Duty Stuart Director | Grant or award · Stock Options (Right to buy) | +28,000 | $4.08 | $114K | 28,000 |
| 2026-06-24 | Mendelsohn Michael Director | Grant or award · Stock Options (Right to buy) | +28,000 | $4.08 | $114K | 28,000 |
| 2026-06-24 | Biller Scott Director | Grant or award · Stock Options (Right to buy) | +28,000 | $4.08 | $114K | 28,000 |
| 2026-06-24 | Cole Douglas G. Director | Grant or award · Stock Options (Right to buy) | +28,000 | $4.08 | $114K | 28,000 |
| 2026-06-24 | Lynch Thomas J. Jr. Director | Grant or award · Stock Options (Right to buy) | +28,000 | $4.08 | $114K | 28,000 |
| 2026-06-24 | SMITH IAN F Director | Grant or award · Stock Options (Right to buy) | +28,000 | $4.08 | $114K | 28,000 |
| 2026-06-24 | GILL SIMBA Director | Grant or award · Stock Options (Right to buy) | +28,000 | $4.08 | $114K | 28,000 |
| 2026-06-24 | PARSHALL B LYNNE Director | Grant or award · Stock Options (Right to buy) | +28,000 | $4.08 | $114K | 28,000 |
| 2026-04-10 | GOTTSCHALK ADRIAN Chief Executive Officer | Gift | −59,208 | 240,792 | ||
| 2026-04-10 | GOTTSCHALK ADRIAN Chief Executive Officer | Gift | +59,208 | 270,912 | ||
| 2026-04-09 | GOTTSCHALK ADRIAN Chief Executive Officer | Gift | −47,497 | 0 | ||
| 2026-04-09 | GOTTSCHALK ADRIAN Chief Executive Officer | Gift | +47,497 | 211,704 | ||
| 2026-02-23 | Maynard Ryan D Chief Financial Officer | Grant or award · Stock Option (right to buy) | +400,000 | $5.75 | $2.3M | 400,000 |
| 2026-02-05 | GOTTSCHALK ADRIAN Chief Executive Officer | Grant or award · Stock option (right to buy) | +1,075,000 | $5.23 | $5.6M | 1,075,000 |
| 2026-01-30 | Rivkin Anna Chief Business Officer | Grant or award · Stock option (right to buy) | +165,000 | $5.71 | $942K | 165,000 |
| 2026-01-30 | Costa Carlos Chief People Officer | Grant or award · Stock option (right to buy) | +230,000 | $5.71 | $1.3M | 230,000 |
| 2026-01-30 | LaCascia Michael Chief Legal Officer | Grant or award · Stock option (right to buy) | +295,000 | $5.71 | $1.7M | 295,000 |
| 2026-01-30 | Bellon Steven F. Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +300,000 | $5.71 | $1.7M | 300,000 |
| 2026-01-30 | Cardama Alfonso Quintas Chief Medical Officer | Grant or award · Stock option (right to buy) | +300,000 | $5.71 | $1.7M | 300,000 |
Page 1 of 9 · 177 trades